Nammex Establishes Scientific Advisory Board to Advance Research and Testing

Nammex Mushrooms, Inc., a supplier of certified organic functional mushroom extracts, has formed a Scientific Advisory Board (SAB).¹ The advisory board will provide scientific guidance to Nammex’s management team and board of directors, and will oversee areas including scientific substantiation, research design, analytical testing, quality systems, and ethical standards for the company’s organic mushroom extracts and fungi-derived ingredients.

What is the Purpose of the New Nammex Scientific Advisory Board?

According to the company, the SAB is designed to support accurate, evidence-based labeling and marketing, precise product characterization, and innovation within functional mycology science. It will function as an independent, multidisciplinary think tank to generate new concepts and strategies. Bill Chioffi, Chief Operating Officer at Nammex, highlighted how the initiative consolidates the individual efforts of the company's retained consultants into a single collaborative group. “Nammex has always sought the opinion of other experts on scientific aspects of mushrooms and applied mycology and it seemed obvious to coalesce the individual efforts of our retained consultants into a group think tank,” he stated. “While we anticipate expanding the membership, this core group brings significant expertise and innovative energy to Nammex.”

Underscoring this focus on scientific infrastructure, Nammex recently introduced ErinaPrime, a 100% pure lion’s mane mycelium ingredient standardized to 1% erinacine A.² The compound has become a focus of neurocognitive health research. Developed through a partnership with Novelera, the ingredient addresses common market challenges regarding ingredient variability. Unlike standard options cultivated on grain substrates, it is produced using a specialized submerged liquid fermentation process and freeze-dried to preserve fragile, neurocognitive health-targeting erinacines without chemical extraction solvents. Potency is verified via independent accredited laboratory testing.

Who is Serving on the Board and How Will It Be Managed?

The core advisory board comprises seven professionals specializing in herbal medicine, ethnopharmacology, chemistry, and veterinary science:

• Lee Carroll: A medical herbalist, educator, and product developer based in Brisbane, Australia, with over 30 years of industry experience, with 23 years of experience teaching herbal medicine to healthcare professionals.
• Jeff Chilton: An ethnomycologist and founder and president of Nammex, who has operated in the North American medicinal mushroom industry for more than 50 years.
• Steven Dentali, Ph.D.: A natural product chemist and botanical ingredient authority with more than 30 years of post-graduate experience in the herbal supplement sector. He is also the founder of Dentali Botanical Sciences.
• Dennis McKenna, Ph.D.: An ethnopharmacologist, research pharmacognosist, and author. McKenna is a founding board member and Director of Ethnopharmacology at the nonprofit Heffter Research Institute, and has served as a long-term advisor to Nammex.
• Robert Silver, DVM, MS, FACVBM: An integrative veterinarian and Chief Veterinary Officer for Real Mushrooms, who holds advanced degrees in veterinary medicine and cardiopulmonary physiology.
• Anna Sitkoff, N.D.: A licensed naturopathic doctor and medicinal mushroom researcher in Poulsbo, Washington, specializing in applied mycology and clinical applications of fungi. She has previously studied Fomitopsis cajanderi (rosy polypore) for its effects on cancer cell lines.
• Kevin Spelman, Ph.D., MCPP: A botanical medicine pharmacologist, clinician, and researcher with 30 years of clinical experience in Ayurveda and western phytotherapy.

The SAB will meet periodically with Nammex leadership, including the Chief Executive Officer, Chief Operating Officer, and the QPIC/Lab Director, to ensure scientific initiatives align with corporate strategy. Nammex compensates board members for their time, and all participants must disclose potential conflicts of interest.

References

1. Nammex. Nammex Announces Scientific Advisory Board to Ensure Products, Processes, Research, Data and Communications are Supported by Scientific Evidence. June 8, 2026. Accessed July 8, 2026. Press release provided via email.
2. Saraceno N. Lion’s Mane Ingredient Targets Standardized Erinacine A. June 2, 2026. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/lion-s-mane-ingredient-targets-standardized-erinacine-a